Riskpilot← Back to searchSign inGet full accessVIKINGKLINIKKEN AS
ASActiveOrg 918364307Jåttåvågveien 11A, 4020 StavangerTraditional, complementary and alternative medicine activities · NACE 8696Est. 20170 employees
Revenue 2024
NOK 7,4M
+14% vs 2023
EBITDA margin
3.9%
+226% vs 2023
Equity ratio
-28.7%
Financial strength
Net profit 2024
NOK 89K
+121% vs 2023
| Revenue | NOK 7,4M | +14% |
| EBITDA | NOK 291K | +226% |
| Net profit | NOK 89K | +121% |
| Total assets | NOK 847K | +3% |
| Equity | NOK -243K | +27% |
| Employees | 0 | — |
Legal name
VIKINGKLINIKKEN AS
Org number
918364307
Legal form
Aksjeselskap
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
13. januar 2017
Share capital
NOK 300 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Å drive behandling, rehabilitering, trening og forebygging innen idrettsmedisin og fysioterapi.
Address
Jåttåvågveien 11A, 4020 Stavanger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 495 | 5 550 | 6 068 | 6 481 | 7 403 |
| Staff expenses | −0 | −0 | −0 | −11 | −0 |
| EBITDA | 442 | −66 | 211 | −230 | 291 |
| Depreciation & amort. | −57 | −110 | −110 | −111 | −133 |
| EBIT | 386 | −177 | 100 | −341 | 159 |
| Net financials | −32 | −53 | −59 | −76 | −70 |
| Profit before tax | 354 | −229 | 42 | −417 | 89 |
| Tax | 80 | −1 | −0 | −0 | −0 |
| Net profit | 274 | −228 | 42 | −417 | 89 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 264 | 1 458 | 1 357 | 825 | 847 |
| Equity | 271 | 43 | 85 | −332 | −243 |
| Long-term debt | 1 | 1 100 | 987 | 794 | 588 |
| Short-term debt | 991 | 315 | 285 | 363 | 502 |
| Total debt | 993 | 1 415 | 1 272 | 1 157 | 1 090 |
EBITDA margin
3.9%
This company
15.8%
Market median
-75% vs market
20202024
Equity ratio
-28.7%
This company
38.2%
Market median
-175% vs market
20202024
Return on equity
8899000.0%
This company
18.4%
Market median
+48364030% vs market
20202024
Net profit margin
1.2%
This company
8.1%
Market median
-85% vs market
20202024
Asset turnover
8.74×
This company
1.12×
Market median
+680% vs market
20202024
Debt / equity
4.48×
This company
0.62×
Market median
-623% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HØ Chief Executive Officer | Chief Executive Officer | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Former (2) | ||
| Board of Directors | 2021 – 2021 | |
| Chairman | 2021 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 49% | 49% | 2024 | |
| Company | 25.5% | 25.5% | 2024 | |
| Company | 25.5% | 25.5% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Keharo As
VIKINGKLINIKKEN AS Board members of VIKINGKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Halvard Øen Grova | Chief Executive Officer | 0 companies |
| Lars-Peder Nagel | Board of Directors | 0 companies |
| Markus Grass | Board of Directors | 0 companies |
| Eirik Bjørnø | Chairman | 0 companies |
| Kenneth Hammond Rosbach | Board of Directors | 0 companies |
| Eirik Renberg Bjørnø | Chairman | 0 companies |